A multicentred phase III comparative study between single-implant containing 3-ketodesogestrel (Implanon®) and implants containing levonorgestrel (norplant®) II. Vaginal bleeding patterns

Open

Biran Affandi, H.M. Hoesni, R.P. Barns, Rizani Amran, Fitriani Iskandar, N.P. Noerpramono, Lila Dewata, W. Ngartjono, Agus Sopacua, Tjeerd Korver, T. B. Paul Geurts, H. J. T. Coelingh Bennink

1999 Medical Journal of Indonesia Vol. 8 Issue 1 Article Cited by 0 SDG 3SDG 17 Quartile

Abstract

A multicentred Phase III clinical trial was conducted in Indonesia to compare two implantable contraceptives i.e. a single implant contaimng 3-ketodesogestrel (Implanon®) and implants containing levonorgestrel(Norplanfl). Efficacy, acceptability and safety of both implants were reported in paper I. This paper reports the comparison of bleeding patterns. A total of899 women were randomly assigned to each implantable contraceptive The comparison of the bleeding patterns is made using a 90-day reference period approach according to WHO guidelines. A total of883 subjects contributed to reference period analysis. In the Implanon® group 415 subjects contributed to the firs, reference period and 271 to the 12* reference period. In the Norplant group those figures were 417 and 318 respectively. There were Jive subjects (1.1%) in the Implanon® group and 4 in the Norplant group (0.9%) discontinued during the study due to bleeding irregularities. One subject (0.2%) in the Implanon® group and none in the Norplant® group discontinued due to amenorrhea. The median number of heeding spotting days ranged over the first 12 reference periods from 2.0 to 14.0 for Implanon® and from 6 0 to 12 0 for Norplant®, For both groups, the majority of bleeding-spotting days were spotting days. In both groups the incidence of amenorrhea in reference period 3 was higher than in the previous reference periods. In reference periods 3 to 12 amenorrhea occurred statistically significantly more frequent in the Implanon® group compared to Norplant® group. Although the incindence of infrequent bleeding wav initially high (approximately 60% in reference period I). it decreased during the study to about 30% in reference period 3 while no ZinbothgT5 (eXCeptfr RPW) between groups Were observed. The incidences of frequent bleeding and prolonged bleeding were low in both groups. © 1999, Faculty of Medicine, Universitas Indonesia. All rights reserved.

Affiliations

Klinik Raden Saleh Faculty of Medicine, University of Indonesia, Jakarta, Indonesia; Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia; National Family Planning Coordinating Board, Jakarta, Indonesia; Faculty of Medicine, University of North Sumatra, Medan, Indonesia; Adam Malik Hospital, Medan, Indonesia; Faculty of Medicine, Sriwijaya University, Palembang, Indonesia; Dr. A.K. Gani Hospital, Palembang, Indonesia; Gatot Subroto Army Hospital, Jakarta, Indonesia; Faculty of Medicine, Diponegoro University, Semarang, Indonesia; Dr. Karyadi Hospital, Semarang, Indonesia; Faculty of Medicine, Airlangga University, Surabaya, Indonesia; Dr. Soetomo Hospital, Surabaya, Indonesia; Faculty of Medicine, Brawijaya University, Malang, Indonesia; Dr. Saiful Anwar Hospital, Malang, Indonesia; Faculty of Medicine, Hasanuddin University, Ujung Pandang, Indonesia; Dr. Wahidin Soedirohoesodo Hospital, Ujung Pandang, Indonesia; Clinical Development Department, NV Organon, Oss, Netherlands; Medical Services Department, NV Organon, Oss, Netherlands

Research at a Glance

Premium content — register to unlock

Research at a Glance

Register to unlock

Topics & SDG Alignment

Premium content — register to unlock

Topics & SDG Alignment

Register to unlock

Collaboration

Premium content — register to unlock

Collaboration

Register to unlock

Author Profile (Selected)

Premium content — register to unlock

Author Profile (Selected)

Register to unlock

References Overview

Premium content — register to unlock

References Overview

Register to unlock

Journal & Source

Premium content — register to unlock

Journal & Source

Register to unlock

Metadata & Integrity

Premium content — register to unlock

Metadata & Integrity

Register to unlock